Results 131 to 140 of about 44,026 (275)

Congenital hypothyroidism, spiky hair, and cleft palate. [PDF]

, 1989
J. Bamforth, Ieuan A. Hughes, John H. Lazarus, Catharina M. Weaver, Peter S. Harper   +4 more
openalex   +1 more source

Variable Expressivity in Johanson‐Blizzard Syndrome: A Case With Severe Manifestations and a Review of the Literature

JGH Open, Volume 9, Issue 8, August 2025.
ABSTRACT Background Johanson‐Blizzard syndrome (JBS) is an exceedingly rare, autosomal recessively inherited disorder. It affects both males and females equally. Exocrine pancreatic insufficiency is the most common finding of the syndrome. The clinical presentation varies significantly among cases.
Hanaa Ktyman, Dana Chaker, Haya Ahmad, Hazem Kamil, Ali Ajlouni   +4 more
wiley   +1 more source

بررسی بروز کم کاری تیرویید مادرزادی نوزادان در مناطق تحت پوشش دانشگاه‌های علوم پزشکی کرمان و جیرفت [PDF]

, 2012
مقدمه: کم کاری مادرزادی تیرویید از شایع‌ترین بیماری‌های غدد درون‌زیر است. هدف از این مطالعه، تعیین فراوانی کم کاری مادرزادی تیرویید در نوزادان متولد شده در سال 1389 در استان کرمان بود.
ابراهیم محمدی, محمدرضا بانشی, نوذر نخعی,
core  

Mental development in congenital hypothyroidism after neonatal screening. [PDF]

, 1987
R Illig, R. H. Largo, Q Qin, Toni Torresani, P Rochiccioli, Agne Larsson   +5 more
openalex   +1 more source

Portable Bedside Nasal Continuous Positive Airway Pressure in the Delivery Room Reduces Length of Stay

Acta Paediatrica, Volume 114, Issue 8, Page 1945-1952, August 2025.
ABSTRACT Aim Portable bedside nasal continuous positive airway pressure in the delivery room (bedside nCPAP) allows the newborn infant to remain with the mother in the delivery room while receiving nCPAP. This study aimed to evaluate the duration of nCPAP treatment and length of stay (LOS) in newborn infants with respiratory distress receiving bedside ...
Stephanie Balslev Andersen, Janne Eriksen, Anne‐Cathrine Finnemann Viuff, Lia Mendes Pedersen, Ninna Brix   +4 more
wiley   +1 more source

Thyroid-Stimulating Hormone, Prolactin, and Growth Hormone Response to Thyrotropin-Releasing Hormone in Treated Children with Congenital Hypothyroidism [PDF]

, 1985
Joseph Sack, Yuval Shafrir, Dalia Urbach, O. Amado   +3 more
openalex   +1 more source

Management of Maternal Hypothyroidism in Pregnancy: A Danish Regional Study

Clinical Endocrinology, Volume 103, Issue 2, Page 269-276, August 2025.
ABSTRACT Objective Hypothyroidism in pregnant women must be carefully managed to prevent complications. The aim of this study was to evaluate compliance with clinical recommendations for the monitoring and treatment of hypothyroidism in pregnant women and to assess the clinical action upon each biochemical monitoring at different time points in ...
Karoline Schack, Line Meyer Laustsen, Randi Ziska Sørensen, Maja Hjelm Lundgaard, Nanna Maria Uldall Torp, Jesper Karmisholt, Stine Linding Andersen   +6 more
wiley   +1 more source

Drug Usage and Risk for Polypharmacy After Pediatric Solid Organ Transplantation—A National Register Study

Clinical Transplantation, Volume 39, Issue 8, August 2025.
ABSTRACT Background Solid organ transplant (SOT) recipients are at risk for long‐term comorbidities and polypharmacy, potentially affecting quality of life. This study assessed the prevalence of chronic medication use among young adults following pediatric SOT. Methods We included 215 individuals in Finland who underwent kidney (n = 135), liver (n = 41)
Rebekka Salonen, Kira Endén, Mikael Koskela, Kirsi Jahnukainen, Atte Nikkilä, Timo Jahnukainen   +5 more
wiley   +1 more source

71 INCIDENCE OF THYROID ANTIBODIES IN NEWBORNS WITH PERMANENT CONGENITAL HYPOTHYROIDISM [PDF]

, 1985
Annette Grüters, U. Bogner, P. Kotulla, Dagmar l’Allemand, H. Schleusener, Bruno Weber, H Helge   +6 more
openalex   +1 more source

Glucagon‐like peptide 1 (GLP‐1) receptor agonists' use during pregnancy: Safety data from regulatory clinical trials

Diabetes, Obesity and Metabolism, Volume 27, Issue 8, Page 4102-4108, August 2025.
Abstract Aims The prevalence of diabetes and obesity continues to rise in women of reproductive age, with significant implications for both mother and foetus. Glucagon‐like peptide‐1 receptor agonists are effective treatments of diabetes and obesity. However, no Glucagon‐like peptide‐1 receptor agonists are currently approved for use during pregnancy ...
Claire H. Parker, Craig Slattery, Donal J. Brennan, Carel W. le Roux   +3 more
wiley   +1 more source